Menu Fermer

Articles sur RandD

Affichage de 801 à 820 de 2987 articles

Afrigen, a biotechnology company based in Cape Town, South Africa, is developing Africa’s first proprietary COVID-19 vaccine. Kristin Palitza/picture alliance via Getty Images

How trying to copy a COVID vaccine changes the outlook for African countries

With the manufacturing capacity and access to relevant technology, African countries can reduce their dependency on international manufacturers for vaccines.
New technologies can bolster the production of important crops to feed billions of people. Shutterstock

South Africa should rethink regulations on genetically modified plants

A regulatory approach will place an unnecessary burden on bio-innovators. This will discourage local investment for in-house R&D, as well as projects in the public sector.
The large public health apparatus assembled to fight Ebola created more problems. Alexis Huguet/AFP via Getty Images

Lessons from the DRC’s 10th Ebola epidemic: the people may know best

International epidemic management involves ceding to foreign experts who possess, at best, a surface-level understanding of a very complex region.
As the pandemic winds down, continual surveillance of wild animals is vital to ensure that it doesn’t switch to another sphere of life. Kamil Martinovsky/ shutterstock

COVID infection of three lions and a puma in private South African zoo points to need for wider surveillance

A growing body of research shows that COVID-19 protocols should be extended to areas in which there is a human-animal interface such as zoos, wildlife sanctuaries and game farms.

Les contributeurs les plus fréquents

Plus